These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 8714497)
1. 'STAR' war against coronary thrombosis. Gambhir DS; Gambhir J Indian Heart J; 1995; 47(5):459-60. PubMed ID: 8714497 [No Abstract] [Full Text] [Related]
2. Effects of recombinant staphylokinase on coronary thrombosis in Chinese experimental miniature swine. Liu JX; Shang XH; Fu JH; Li XZ; Wang G Acta Pharmacol Sin; 2002 Jun; 23(6):509-15. PubMed ID: 12060524 [TBL] [Abstract][Full Text] [Related]
3. Thrombolysis. An approach still on the move. Verstraete M Drugs; 1989 Feb; 37(2):116-22. PubMed ID: 2495217 [No Abstract] [Full Text] [Related]
4. New standard for success of thrombolytic therapy. An earnest proposal. Forrester JS Circulation; 1995 Oct; 92(8):2026-8. PubMed ID: 7554175 [No Abstract] [Full Text] [Related]
5. Fibrolase, an active thrombolytic enzyme in arterial and venous thrombosis model systems. Markland FS Adv Exp Med Biol; 1996; 391():427-38. PubMed ID: 8726081 [No Abstract] [Full Text] [Related]
6. [Thrombolytic treatment of type A right atrial thrombi]. Greco F G Ital Cardiol; 1999 Aug; 29(8):937-8. PubMed ID: 10488457 [No Abstract] [Full Text] [Related]
8. [Staphylokinase for a better thrombolytic treatment of heart and platelet diseases]. Vanderschueren S Verh K Acad Geneeskd Belg; 2000; 62(1):69-75. PubMed ID: 10769618 [TBL] [Abstract][Full Text] [Related]
9. Proceedings of the TCT: questions surround antithrombotic therapy in coronary DES implantation. White J J Interv Cardiol; 2006 Jun; 19(3):232-5. PubMed ID: 16724964 [No Abstract] [Full Text] [Related]
10. A pilot study on bolus administration of recombinant staphylokinase for coronary artery thrombolysis. Vanderschueren S; Collen D; van de Werf F Thromb Haemost; 1996 Oct; 76(4):541-4. PubMed ID: 8902993 [TBL] [Abstract][Full Text] [Related]
11. [Management of acute coronary syndrome. New pharmacologic approaches]. Galvani M; Nicolini FA; Ferrini D; Ottani F G Ital Cardiol; 1999; 29 Suppl 4():23-7. PubMed ID: 10686688 [No Abstract] [Full Text] [Related]
12. [New antithrombotic drugs in cardiovascular disease]. Golino P; Cimmino G; Porchetta I; Spadera M; Volpe M; Calabrò R G Ital Cardiol (Rome); 2006 Feb; 7(2):109-18. PubMed ID: 16532722 [TBL] [Abstract][Full Text] [Related]
13. Viewpoint: megatrials and the development of antithrombotics. Polak M Circulation; 2006 Jun; 113(25):f97. PubMed ID: 16801471 [No Abstract] [Full Text] [Related]
14. Alfimeprase to succeed Genentech's alteplase? Vastag B Nat Biotechnol; 2006 Aug; 24(8):875-6. PubMed ID: 16900112 [No Abstract] [Full Text] [Related]
15. Myocardial salvage--a perspective. Gordon GD; Commerford PJ S Afr Med J; 1988 May; 73(9):509-10. PubMed ID: 3375935 [No Abstract] [Full Text] [Related]
16. Thrombolytic efficacy of native recombinant staphylokinase on femoral artery thrombus of rabbits. Li CJ; Huang J; Yang ZJ; Cao KJ Acta Pharmacol Sin; 2007 Jan; 28(1):58-65. PubMed ID: 17184583 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of carboxypeptidase U (TAFIa) activity improves rt-PA induced thrombolysis in a dog model of coronary artery thrombosis. Björkman JA; Abrahamsson TI; Nerme VK; Mattsson CJ Thromb Res; 2005; 116(6):519-24. PubMed ID: 16181987 [TBL] [Abstract][Full Text] [Related]
18. Triple antithrombotic management after stent implantation: when and how? Schömig A; Sarafoff N; Seyfarth M Heart; 2009 Aug; 95(15):1280-5. PubMed ID: 19605755 [No Abstract] [Full Text] [Related]
19. [Symptomatic therapy refractory myocardial ischemia in coronary heart disease. Chronic intermittent urokinase therapy and invasive therapeutic measures]. Leschke M; Schoebel FC; Strauer BE Internist (Berl); 1996 Jun; 37(6):597-606. PubMed ID: 8767992 [No Abstract] [Full Text] [Related]